Scott Lonning

4.7k total citations · 1 hit paper
39 papers, 3.6k citations indexed

About

Scott Lonning is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Scott Lonning has authored 39 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Oncology and 8 papers in Immunology. Recurrent topics in Scott Lonning's work include TGF-β signaling in diseases (14 papers), Cancer Cells and Metastasis (8 papers) and HIV Research and Treatment (4 papers). Scott Lonning is often cited by papers focused on TGF-β signaling in diseases (14 papers), Cancer Cells and Metastasis (8 papers) and HIV Research and Treatment (4 papers). Scott Lonning collaborates with scholars based in United States, Malaysia and South Korea. Scott Lonning's co-authors include Christina H. Stuelten, Jay A. Berzofsky, Masaki Terabe, Mary Helen Barcellos‐Hoff, John M. McPherson, Beverly A. Teicher, Chung Lee, Ximing J. Yang, Thomas L. Jang and Irwin Park and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Scott Lonning

38 papers receiving 3.5k citations

Hit Papers

Protection from Obesity and Diabetes by Blockade of TGF-β... 2011 2026 2016 2021 2011 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott Lonning United States 28 1.6k 1.4k 979 415 404 39 3.6k
Bruno Azzarone France 37 1.1k 0.7× 1.0k 0.7× 2.0k 2.1× 422 1.0× 412 1.0× 132 4.1k
Birgitta Sander Sweden 37 1.0k 0.7× 1.3k 0.9× 1.4k 1.5× 213 0.5× 262 0.6× 141 4.4k
Stephen J. Brandt United States 28 2.0k 1.3× 1.0k 0.7× 849 0.9× 413 1.0× 242 0.6× 71 4.3k
Sara M. Bodner United States 18 1.6k 1.0× 2.1k 1.5× 915 0.9× 207 0.5× 494 1.2× 27 3.9k
Jonathan R. Keller United States 33 1.7k 1.1× 771 0.6× 1.3k 1.3× 271 0.7× 343 0.8× 91 3.4k
Hiromi Tagoh United Kingdom 31 1.4k 0.9× 1.0k 0.7× 1.7k 1.7× 350 0.8× 253 0.6× 59 3.9k
Mitsujiro Osawa Japan 19 1.8k 1.1× 1.3k 0.9× 892 0.9× 230 0.6× 343 0.8× 31 3.7k
Deborah L. Galson United States 35 2.3k 1.4× 1.4k 1.0× 1.0k 1.0× 200 0.5× 802 2.0× 83 3.9k
Kai Schledzewski Germany 30 1.6k 1.0× 724 0.5× 1.4k 1.4× 245 0.6× 301 0.7× 60 3.7k
Jason A. Hackney United States 29 1.7k 1.1× 1.2k 0.8× 2.1k 2.2× 173 0.4× 295 0.7× 45 4.7k

Countries citing papers authored by Scott Lonning

Since Specialization
Citations

This map shows the geographic impact of Scott Lonning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Lonning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Lonning more than expected).

Fields of papers citing papers by Scott Lonning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Lonning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Lonning. The network helps show where Scott Lonning may publish in the future.

Co-authorship network of co-authors of Scott Lonning

This figure shows the co-authorship network connecting the top 25 collaborators of Scott Lonning. A scholar is included among the top collaborators of Scott Lonning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott Lonning. Scott Lonning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shan, Changliang, Hee‐Bum Kang, Shannon Elf, et al.. (2014). Tyr-94 Phosphorylation Inhibits Pyruvate Dehydrogenase Phosphatase 1 and Promotes Tumor Growth. Journal of Biological Chemistry. 289(31). 21413–21422. 51 indexed citations
2.
Fan, Jun, Hee‐Bum Kang, Changliang Shan, et al.. (2014). Tyr-301 Phosphorylation Inhibits Pyruvate Dehydrogenase by Blocking Substrate Binding and Promotes the Warburg Effect. Journal of Biological Chemistry. 289(38). 26533–26541. 62 indexed citations
3.
Ling, Hong, Donna Hempel, Jingzang Tao, et al.. (2013). Transforming Growth Factor β Neutralization Ameliorates Pre-Existing Hepatic Fibrosis and Reduces Cholangiocarcinoma in Thioacetamide-Treated Rats. PLoS ONE. 8(1). e54499–e54499. 71 indexed citations
4.
Hezel, Aram F., Vikram Deshpande, Stephanie M. Zimmerman, et al.. (2012). TGF-β and αvβ6 Integrin Act in a Common Pathway to Suppress Pancreatic Cancer Progression. Cancer Research. 72(18). 4840–4845. 77 indexed citations
5.
Li, Zhaoyang, Yanli Pang, Sudheer Kumar Gara, et al.. (2012). Gr‐1+CD11b+ cells are responsible for tumor promoting effect of TGF‐β in breast cancer progression. International Journal of Cancer. 131(11). 2584–2595. 60 indexed citations
6.
Yadav, Hariom, Celia Quijano, Anil K. Kamaraju, et al.. (2011). Protection from Obesity and Diabetes by Blockade of TGF-β/Smad3 Signaling. Cell Metabolism. 14(1). 67–79. 553 indexed citations breakdown →
7.
Zhang, Qiang, Lin Chen, Brian T. Helfand, et al.. (2011). TGF-β Regulates DNA Methyltransferase Expression in Prostate Cancer, Correlates with Aggressive Capabilities, and Predicts Disease Recurrence. PLoS ONE. 6(9). e25168–e25168. 57 indexed citations
8.
Biswas, Swati, Jeffry S. Nyman, JoAnn Alvarez, et al.. (2011). Anti-Transforming Growth Factor ß Antibody Treatment Rescues Bone Loss and Prevents Breast Cancer Metastasis to Bone. PLoS ONE. 6(11). e27090–e27090. 77 indexed citations
9.
Nishimura, Emi K., Misa Suzuki, Vivien Igras, et al.. (2010). Key Roles for Transforming Growth Factor β in Melanocyte Stem Cell Maintenance. Cell stem cell. 6(2). 130–140. 175 indexed citations
10.
Ueda, Ryo, Mitsugu Fujita, Xinmei Zhu, et al.. (2009). Systemic Inhibition of Transforming Growth Factor-β in Glioma-Bearing Mice Improves the Therapeutic Efficacy of Glioma-Associated Antigen Peptide Vaccines. Clinical Cancer Research. 15(21). 6551–6559. 94 indexed citations
11.
Terabe, Masaki, Elena Ambrosino, Shun Takaku, et al.. (2009). Synergistic Enhancement of CD8+ T Cell–Mediated Tumor Vaccine Efficacy by an Anti–Transforming Growth Factor-β Monoclonal Antibody. Clinical Cancer Research. 15(21). 6560–6569. 83 indexed citations
12.
Nam, Jeong‐Seok, Masaki Terabe, Mi‐Jin Kang, et al.. (2008). Transforming Growth Factor β Subverts the Immune System into Directly Promoting Tumor Growth through Interleukin-17. Cancer Research. 68(10). 3915–3923. 198 indexed citations
13.
Nam, Jeong‐Seok, Masaki Terabe, Mizuko Mamura, et al.. (2008). An Anti–Transforming Growth Factor β Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments. Cancer Research. 68(10). 3835–3843. 187 indexed citations
14.
Fattouh, Ramzi, Katherine Arias, Jill R. Johnson, et al.. (2008). Transforming Growth Factor-β Regulates House Dust Mite–induced Allergic Airway Inflammation but Not Airway Remodeling. American Journal of Respiratory and Critical Care Medicine. 177(6). 593–603. 78 indexed citations
15.
Frantz, Stefan, Kai Hu, Anna Adamek, et al.. (2008). Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction. Basic Research in Cardiology. 103(5). 485–492. 174 indexed citations
16.
Wong, Larry, Thomas L. Jang, Ali Shah, et al.. (2007). Tumor Evasion of the Immune System by Converting CD4+CD25− T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-β. The Journal of Immunology. 178(5). 2883–2892. 362 indexed citations
17.
Nakanishi, Hidehiko, Takahiro Sugiura, James B. Streisand, Scott Lonning, & Jesse D. Roberts. (2007). TGF-β-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung. American Journal of Physiology-Lung Cellular and Molecular Physiology. 293(1). L151–L161. 117 indexed citations
18.
Nam, Jeong‐Seok, Mi‐Jin Kang, Christina H. Stuelten, et al.. (2006). Bone Sialoprotein Mediates the Tumor Cell–Targeted Prometastatic Activity of Transforming Growth Factor β in a Mouse Model of Breast Cancer. Cancer Research. 66(12). 6327–6335. 72 indexed citations
19.
Ziegler, Robin J., Scott Lonning, Donna Armentano, et al.. (2003). AAV2 Vector Harboring a Liver-Restricted Promoter Facilitates Sustained Expression of Therapeutic Levels of α-Galactosidase A and the Induction of Immune Tolerance in Fabry Mice. Molecular Therapy. 9(2). 231–240. 111 indexed citations
20.
Nunamaker, R. A., Adalberto Á. Pérez de León, Corey L. Campbell, & Scott Lonning. (2000). Oral Infection of <I>Culicoides sonorensis</I> (Diptera: Ceratopogonidae) by Vesicular Stomatitis Virus. Journal of Medical Entomology. 37(5). 784–786. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026